Experiment set2H16 for Phaeobacter inhibens DSM 17395
marine broth with benzoic acid 0.145 mg/ml
Group: stressMedia: marine_broth_2216 + benzoic acid (0.145 mg/ml)
Culturing: Phaeo_ML1, 48 well microplate; Tecan Infinite F200, Aerobic, at 25 (C), shaken=orbital
By: Jordan on 8/1/2013
Media components: 5 g/L Bacto Peptone, 1 g/L Yeast Extract, 0.1 g/L Ferric citrate, 19.45 g/L Sodium Chloride, 5.9 g/L Magnesium chloride hexahydrate, 3.24 g/L Magnesium sulfate, 1.8 g/L Calcium chloride, 0.55 g/L Potassium Chloride, 0.16 g/L Sodium bicarbonate, 0.08 g/L Potassium bromide, 34 mg/L Strontium chloride, 22 mg/L Boric Acid, 4 mg/L Sodium metasilicate, 2.4 mg/L sodium fluoride, 8 mg/L Disodium phosphate
Growth plate: 614 C3,C4
Specific Phenotypes
For 5 genes in this experiment
For stress benzoic acid in Phaeobacter inhibens DSM 17395
For stress benzoic acid across organisms
SEED Subsystems
| Subsystem | #Specific |
|---|---|
| Choline and Betaine Uptake and Betaine Biosynthesis | 1 |
| p-Hydroxybenzoate degradation | 1 |
Metabolic Maps
Color code by fitness: see overview map or list of maps.
Maps containing gene(s) with specific phenotypes:
- Glycine, serine and threonine metabolism
- Benzoate degradation via hydroxylation
- 2,4-Dichlorobenzoate degradation
MetaCyc Pathways
Pathways that contain genes with specific phenotypes:
| Pathway | #Steps | #Present | #Specific |
|---|---|---|---|
| creatinine degradation I | 4 | 2 | 1 |
| 4-methylphenol degradation to protocatechuate | 4 | 1 | 1 |
| 4-chlorobenzoate degradation | 4 | 1 | 1 |
| 4-coumarate degradation (aerobic) | 5 | 1 | 1 |
| creatinine degradation II | 5 | 1 | 1 |
| bisphenol A degradation | 5 | 1 | 1 |
| 4-hydroxymandelate degradation | 6 | 1 | 1 |
| spongiadioxin C biosynthesis | 7 | 1 | 1 |
| glycine betaine degradation I | 8 | 7 | 1 |
| polybrominated dihydroxylated diphenyl ethers biosynthesis | 8 | 1 | 1 |
| toluene degradation III (aerobic) (via p-cresol) | 11 | 7 | 1 |
| superpathway of aerobic toluene degradation | 30 | 11 | 1 |
| superpathway of aromatic compound degradation via 3-oxoadipate | 35 | 14 | 1 |
| superpathway of aromatic compound degradation via 2-hydroxypentadienoate | 42 | 10 | 1 |